PlantForm Corp.

Canadian #biopharmaceutical company with a plant-based platform for #biosimilars and other specialty antibody and protein drugs. #biotech #biodefense

[PlantForm Corp. @PlantFormCorp]

PlantForm is proud to be advancing biologics innovation with CDMO services using our cost-effective, plant-based vivoXPRESS manufacturing platform.

Learn more: https://t.co/HohAfOXJOj

#cdmo #biologics #biopharma #BIO2022 #LimitlessTogether

[US Capital Global @USCapGlobal]

$25MM Investment Opportunity in Plant-Based Pharmaceuticals Company

Plantform Corporation is developing plant-made pharmaceuticals for exposure to chemical weapons, among other breakthroughs.

Thursday, June 6th, 8:00AM PDT
Online event

Learn more: https://t.co/sjz7qoOD0n

#event #webinar #plantbased #pharmaceuticals #medical #illnesses #clinical #biotechnology #biodefense #vaccines #investment #investing #investors #finance #business #funding #equity

[Dr. Jennifer Geddes-McAlister @JGMProteomics]

This work beautifully integrates the power of proteomics and metabolomics with the promise of plants for drug discovery. Very excited to see it published! @PlantFormCorp @CNPN_org

[PlantForm Corp. @PlantFormCorp]

We'll be at the International Society for Plant Molecular Farming (ISPMF) Conference May 6-8! 🌿

Thank you to #CanExport Innovation @tcs_sdc for supporting our work to forge new partnerships that bring Canadian biotech innovation to the world!

#export #ISPMF2024

[PlantForm Corp. @PlantFormCorp]

Exciting news! @PlantFormCorp and @3dbiofibr have been awarded $1.3M from @NGen_Canada to advance recombinant human collagen fiber manufacturing technology.

Read the full news release: https://t.co/8snDdRaDsi

#collagen #biotech #innovation

[PlantForm Corp. @PlantFormCorp]

Read this @BioProcessIntl article about our work leveraging plant-based protein-expression systems for #biodefense applications:

https://t.co/AbcJ1SkXgT

[PlantForm Corp. @PlantFormCorp]

News Release: @PlantFormCorp and @SwiftPharmaInc announce new licensing agreement to develop plant-made antibodies, proteins and vaccines for global markets

Read more: https://t.co/yydrC28ncV

#biopharma #biotech #antibody

[PlantForm Corp. @PlantFormCorp]

Press release: AntoXa Corporation and SwiftPharma Sign Exclusive Collaboration Agreement to Support the Development and Commercialization of a Plant-Made Antibody Against Ricin Exposure

Full release: https://t.co/la4fSy4k17

[PlantForm Corp. @PlantFormCorp]

PlantForm has 2 immediate job openings!
1️⃣ Biotechnology Technician (Guelph or Bolton, ON).
2️⃣ Research Associate 1 (Bolton, ON).

See the employment postings here: https://t.co/uy2apKGbuX

#biotech #biopharma

[PlantForm Corp. @PlantFormCorp]

Press Release: U.S. Patent Office allows @PlantFormCorp's patent application for novel approach to boost yields of plant-based protein products

Full release:

https://t.co/Fl4FPDs068

#biopharmaceutical #antibodytherapeutics #innovation

[PlantForm Corp. @PlantFormCorp]

Read more here: https://t.co/NGGVtMhaGl

#ricin #biopharma #antibody

[PlantForm Corp. @PlantFormCorp]

Ricin is in the news again: this lethal substance, found naturally in castor beans, is 6,000 times deadlier than cyanide and a tiny amount can cause death within 36 hours.

https://t.co/5rgdNdg3Qj

[PlantForm Corp. @PlantFormCorp]

The PhD9 antibody drug candidate developed by DRDC prevents ricin from penetrating cells. The process has received United States Patent No. 11,447,789.

[PlantForm Corp. @PlantFormCorp]

PRESS RELEASE: PlantForm and @UBC researcher Dr. Joerg Bohlmann receive @glyconet_nce funds to develop novel, plant-based treatment option for Type-2 diabetes

Read the full release here: https://t.co/K4J1RXV0gl

[PlantForm Corp. @PlantFormCorp]

PRESS RELEASE: PlantForm Corporation and Bio-Manguinhos/Fiocruz sign new agreement to develop a #biosimilar pembrolizumab cancer drug and up to 5 future products for the Brazilian and other world markets.

Full release: https://t.co/45h0EKESBA

[Nicoya @Nicoya_Life]

In our latest blog post, we examine the trends shaping the #biosimilars industry & discuss the impact of innovative techs on biosimilar development. Learn how @PlantFormCorp's vivoXPRESS® & Alto Digital #SPR can streamline biosimilar production.

Link: https://t.co/2rBQgBZmKF

[PlantForm Corp. @PlantFormCorp]

AntoXa, a wholly-owned subsidiary of PlantForm Corporation, has an exclusive license from DRDC to develop and produce the PhD9 monoclonal antibody treatment in plants for sale in markets worldwide.

[PlantForm Corp. @PlantFormCorp]

PRESS RELEASE: U.S. Patent Granted for Made-in-Canada Ricin Antibody Technology

Read the full press release:

https://t.co/FBfXs9CtbS

[PlantForm Corp. @PlantFormCorp]

The patent is for a plant-based manufacturing process to produce an antibody for treatment of ricin exposure, an outcome of R&D by AntoXa Corporation under contract with Defence Research and Development Canada (DRDC), an Agency of the Canadian Department of National Defence.